Business ❯Finance ❯Investments ❯Stock Market

Pharmaceutical Stocks

Trump Announces Major Tariff on Pharmaceutical Imports, Targeting Global Supply Chains

Novo Nordisk Faces Investor Turmoil as Wegovy Sales and Market Share Decline

Novo Nordisk Reports Doubling Wegovy Sales, Projects Slower Growth in 2025

Novo Nordisk's Amycretin Shows 22% Weight Loss in Trial, Boosting Stock

Moderna Cuts 2025 Revenue Forecast by $1 Billion, Shares Drop Over 20%

Novo Nordisk Expands Wegovy Supply Amid Compounding Drug Concerns

Eli Lilly's Weight-Loss Drugs Drive Record Q2 Revenue Surge

Pfizer and Merck Diverge in Q2 Performance Amid Revised Forecasts